A platform for research: civil engineering, architecture and urbanism
Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F3591 mutation of BCR-ABL oncogene - Short communication
Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F3591 mutation of BCR-ABL oncogene - Short communication
Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F3591 mutation of BCR-ABL oncogene - Short communication
Baranska, M. (author) / Lewandowski, K. (author) / Gniot, M. (author) / Iwola, M. (author) / Lewandowska, M. (author) / Komarnicki, M. (author)
JOURNAL OF APPLIED GENETICS ; 49 ; 201-204
2008-01-01
4 pages
Article (Journal)
English
DDC:
576.5
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Short coupled Ventricular Fibrillation in a patient with TRPM4 mutation
Elsevier | 2025
|Concreting challenges overcome
British Library Online Contents | 2005
|